Depression in patients with asthma

Advances in Psychosomatic Medicine

Volumn 24, Issue , 2003, Pages 42-50

  Zielinski, Tanya A ^a   Sherwood Brown, E ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASTHMA; COMORBIDITY; DEPRESSION; HUMAN; PATIENT ATTITUDE; PSYCHOLOGICAL ASPECT; PSYCHOSOMATIC DISORDER; REVIEW;

ASTHMA; COMORBIDITY; DEPRESSIVE DISORDER; HUMANS; PSYCHOPHYSIOLOGIC DISORDERS; SICK ROLE;

EID: 0642309292     PISSN: 00653268     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000073779     Document Type: Article

References (44)

1. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, Wittchen HU, Kendler KS: Lifetime and 12 month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 1994;51:8-19.
2. Katon W, Schulberg H: Epidemiology of depression in primary care. Gen Hosp Psychiatry 1992;14:237-247.
3. Wells KB, Stewart A, Hays RD, Burnam MA, Rogers W, Daniels M, Berry S, Greenfield S, Ware J: The functioning and well-being of depressed patients. Results from the Medical Outcomes Study. JAMA 1989;262:914-919.
4. Wells KB, Rogers W, Burman MA, Camp P: Course of depression in patients with hypertension, myocardial infarction, or insulin-dependent diabetes. Am J Psychiatry 1993;150:632-638.
5. Frasure-Smith N, Lesperance F, Talajic M: Depression and 18-month prognosis after myocardial infarction. Circulation 1995;91:999-1005.
6. Weiss KB, Wagener DK: Changing patterns of asthma mortality identifying target populations at high risk. JAMA 1990;264:1683-1687.
7. CDC: Leads from the morbidity and mortality weekly report, Atlanta, GA. Asthma - United States, 1980-1990. JAMA 1992;268:1995-1996.
8. American Psychiatric Association: Diagnostic and Statistical Manual for Mental Disorders: DSMIVTR™: Fourth Edition Text Revision. Washington, American Psychiatric Association, 2000.
9. Zielinski TA, Brown ES, Nejtek VA, Moore JJ, Rush AJ: Depression in asthma: Prevalence and clinical implications. Prim Care Comp J Clin Psychiatry 2000;2:153-158.
10. Badoux A, Levy DA: Psychologic symptoms in asthma and chronic urticaria. Ann Allergy 1994; 72:229-234.
11. Lyketsos CG, Lyketsos GC, Richardson SC, Beis A: Dysthymic states and depressive syndromes in physical conditions of presumably psychogenic origin. Acta Psychiatr Scand 1987;76:529-534.
12. Dy er CAE, Sinclair AJ: A hospital-based case-control study of quality of life in older asthmatics. Eur Respir J 1997;10:337-341.
13. Surís JC, Parera N, Puig C: Chronic illness and emotional distress in adolescence. J Adolesc Health 1996;19/2:153-156.
14. Seigel WM, Golden NH: Depression, self-esteem, and life events in adolescents with chronic diseases. J Adolesc Health 1990;11:501-504.
15. Padur JS, Rapoff MA, Houston BK, Barnard M, Danovsky M, Olson NY, Moore WV, Vats TS, Lieberman B: Psychosocial adjustment and the role of functional status for children with asthma. J Asthma 1995;32:345-353.
16. Yellowlees PM, Haynes S, Potts N, Ruffin RE: Psychiatric morbidity in patients with life-threatening asthma: Initial report of a controlled study. Med J Aust 1988;149/5:246-249.
17. Brown ES, Khan DA, Mahadi S: Psychiatric diagnoses in inner city outpatients with moderate to severe asthma. Int J Psychiatry Med 2000;30:319-327.
18. Nejtek VA, Brown ES, Khan DA, Moore JJ, Van Wagner J, Perantie DC: Prevalence of mood disorders and relationship to asthma severity in patients at an inner-city asthma clinic. Ann Allergy Asthma Immunol 2001;87:129-133.
19. Allen GM, Hickie I, Gandevia SC, McKenzie DK: Impaired voluntary drive to breathe: A possible link between depression and unexplained ventilatory failure in asthmatic patients. Thorax 1994;49:881-884.
20. Strunk RC, Mrazek DA, Fuhrmann GSW, LaBrecque JF: Physiologic and psychological characteristics associated with deaths due to asthma in childhood. JAMA 1985;254:1193-1198.
21. Picado C, Montserrat JN, de Pablo J, Plaza V, Agusti-Vidal A: Predisposing factors to death after recovery from a life-threatening asthmatic attack. J Asthma 1989;26/4:231-236.
22. Brown ES, Khan DA, Nejtek VA, Thomas NR, Mahadi SF: Depressive symptoms and functioning in asthma patients. Prim Care Psychiatry 2000;6:155-161.
23. Morrison KM, Goli A, Van Wagoner J, Brown ES, Khan DA: Depressive symptoms in inner-city children with asthma. Prim Care Companion J Clin Psychiatry 2002;4:174-177.
24. Bosley CM, Fosbury JA, Cochrane GM: The psychological factors associated with poor compliance with treatment in asthma. Eur Respir J 1995;8:899-904.
25. Janson C, Bjornsson E, Hetta J, Boman G: Anxiety and depression in relation to respiratory symptoms and asthma. Am J Respir Crit Care Med 1994;149:930-934.
26. Rushford N, Tiller JWG, Pain MCF: Perception of natural fluctuations in peak flow in asthma: Clinical severity and psychological correlates. J Asthma 1998;35/3:251-259.
27. Janson-Bjerklie S, Ferketich S, Benner P, Becker G: Clinical markers of asthma severity and risk: Importance of subjective as well as objective factors. Heart Lung 1992;21:265-272.
28. Mellett P: Psychological states of asthmatics after treatment. J Psychosom Res 1973;17:299-302.
29. Lustman PJ, Freedland KE, Griffith LS, Clouse RE: Fluoxetine for depression in diabetes: A randomized double-blind placebo-controlled trial. Diabetes Care 2000;23:618-623.
30. Sugihara H, Ishihara K, Noguchi H: Clinical experience with amitriptyline (tryptanol) in the treatment of bronchial asthma. Ann Allergy 1965;23:422-429.
31. Lechin F, van der Dijs B, Orozco B, Jara H, Rada I, Lechin ME, Lechin AE: The serotonin uptakeenhancing drug tianeptine suppresses asthmatic symptoms in children: A double-blind, crossover, placebo-controlled study. J Clin Pharmacol 1998;38:918-925.
32. Wilson RCD: Antiasthmatic effect of amitriptyline (letter). Can Med Assoc J 1974;111:212.
33. Sanger MD: The treatment of anxiety and depression in the allergic patient. Case report. Ann Allergy 1969;27:506-510.
34. Dilsaver SC, Coffman JA: Cholinergic hypothesis of depression: A reappraisal. J Clin Psychopharmacol 1989;9:173-179.
35. Costello RW, Jacoby DB, Fryer AD: Pulmonary neuronal M2 muscarinic receptor function in asthma and animal models of hyperreactivity. Thorax 1998;53:613-616.
36. Carr RE, Lehrer PM, Hochron SM, Jackson A: Effect of psychological stress on airway impedance in individuals with asthma and panic disorder. J Abnorm Psychol 1996;105:137-141.
37. Lehrer PM, Hochron S, Carr R, Edelberg R, Hamer R, Jackson A, Porges S: Behavioral taskinduced bronchodilation in asthma during active and passive tasks: A possible cholinergic link to psychologically induced airway changes. Psychosom Med 1996;58:413-422.
38. Miller BD, Wood BL: Influence of specific emotional states on autonomic reactivity and pulmonary function in asthmatic children. J Am Acad Child Adolesc Psychiatry 1997;36:669-677.
39. Overstreet DH, Steiner M: Genetic and environmental models of stress-induced depression in rats. Stress Med 1998;14:261-268.
40. Djurie VJ, Cox G, Overstreet DH, Smith L, Dragomir A, Steiner M: Genetically transmitted cholinergic hyperresponsiveness predisposes to experimental asthma. Brain Behav Immun 1998; 13:272-284.
41. Lane SJ, Lee TH: Mechanisms of corticosteroid resistance in asthmatic patients. Int Arch Allergy Immunol 1997;113:193-195.
42. Leung DY, Spahn JD, Szefler SJ: Immunologic basis and management of steroid-resistant asthma. Allergy Asthma Proc 1999;20:9-14.
43. Lowy MT, Reder AT, Antel JP, Meltzer HY: Glucocorticoid resistance in depression: The dexamethasone suppression test and lymphocyte sensitivity to dexamethasone. Am J Psychiatry 1984; 141:1365-1370.
44. Arana GW, Baldessarini JR, Ornsteen M: The dexamethasone suppression test for diagnosis and prognosis in psychiatry. Arch Gen Psychiatry 1994;42:1193-1204.